Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
OPDIVO
E.R. Squibb & Sons, L.L.C.
Tagrisso
(osimertinib)Orphan drugstandardAstraZeneca Pharmaceuticals LP
Kinase Inhibitor [EPC]
12.1 Mechanism of Action Osimertinib is a kinase inhibitor of the epidermal growth factor receptor (EGFR), which binds irreversibly to certain mutant ...
Browse all Squamous cell carcinoma of gallbladder and extrahepatic biliary tract news →
Anthony El-Khoueiry, M.D
SWOG Cancer Research Network
📍 LOS ANGELES, CA
Sandip P Patel
SWOG Cancer Research Network
📍 Birmingham, Alabama
Laura Goff
Vanderbilt-Ingram Cancer Center
Paula Fracasso, MD
University of Virginia
📍 CHARLOTTESVILLE, VA
Scot C. Remick, MD, MD
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
📍 SCARBOROUGH, ME
William Carson
Ohio State University
View all Squamous cell carcinoma of gallbladder and extrahepatic biliary tract specialists →